NTHU Researchers Discover New Gastric Cancer Biomarkers For Tailored Therapy

HSINCHU, Taiwan, Nov 16 (Bernama-BUSINESS WIRE) — A research team led by Professor Wang Wen-ching of the Institute of Molecular and Cellular Biology, National Tsing Hua University (NTHU) has exploited the power of big data to identify two key biomarkers contributing to the proliferation and metastasis of gastric (stomach) cancer. Using the US Food and Drug Administration (FDA)-approved drugs, the team conducted targeted therapy which can effectively eliminate tumor growth and inhibit metastasis, paving the way for a new tailored therapy. Their research has been published in the newest issue of Proceedings of the National Academy of Sciences of the United States.

Finding new ways to treat gastric cancer

Stomach cancer is the fifth most common cancer worldwide, and the second highest mortality rate because of its grueling and difficult treatment for many patients. Wang said that it often happens that by the time someone is diagnosed, cancer cells have already metastasized.

http://mrem.bernama.com/viewsm.php?idm=38695

administrator

Related Articles